Karuna Therapeutics Q3 EPS $(2.38) Down From $(1.72) YoY

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(2.38) per share. This is a 38.37 percent decrease over losses of $(1.72) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

‘We Don’t Plan On Stopping!’ Teamsters’ New Cannabis Contract In Illinois Raises Bar For Big Industry Players

Workers at five Sunnyside Dispensaries — a subsidiary of multi-state cannabis operator Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) — have reached tentative agreements for first union contracts with Teamsters Local 777.

CRLBF